查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1956163

日本病理检测服务市场规模、份额、趋势及预测（按类型、检测服务、最终用途和地区划分），2026-2034年

Japan Pathology Lab Services Market Size, Share, Trends and Forecast by Type, Testing Service, End Use, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本病理检测服务市场规模达349.255亿美元。 IMARC集团预测，到2034年，该市场规模将达到773.933亿美元，2026年至2034年的复合年增长率（CAGR）为9.24%。推动该市场成长的主要因素是数位病理学和人工智慧的快速普及，以及政府推行的数位化医疗转型和精准医疗政策。人口老化和慢性病的盛行率上升，推动了基因组检测和个人化诊断的需求，促使实验室加强次世代定序（NGS）和生物标记分析能力。病理检测服务供应商、人工智慧Start-Ups和製药公司之间的策略合作，正在加速创新，并进一步扩大日本病理检测服务市场的份额。

日本病理检测服务市场的发展趋势：

数位病理学和人工智慧整合技术的日益普及

市场正经历着数位化病理学和人工智慧（AI）融合的重大转变。全切片成像（WSI）技术和云端资料储存的进步正推动实验室从传统显微镜转向数位平台，从而实现更快、更准确的诊断。人工智慧工具正被越来越多地用于辅助病理学家检测异常、减少人为错误并简化工作流程。日本政府大力推动数位化医疗转型以及对精准医疗日益增长的需求正在加速这一趋势。为了因应人口老化带来的病理服务需求成长，日本2024财年的数位医疗预算大幅增加，达到617亿日圆（约4亿美元）。政府尤其重视人工智慧诊断和电子健康记录（EMR）的实施。根据政府估计，到2040年，日本将面临96万名医疗专业人员的缺口，凸显了在检测和诊断领域快速采用数位科技的紧迫性。目前，美日合作主要集中在电子病历标准化、病理学人工智慧开发以及跨境资料交换等方面，旨在实现实验室基础设施的数位现代化。此外，病理检查室与人工智慧Start-Ups的合作正在推动自动化诊断领域的创新，尤其是在癌症检测领域。然而，高昂的实施成本和资料安全隐患等挑战依然存在。儘管存在这些障碍，但对扩充性远距离诊断解决方案日益增长的需求，尤其是在遍远地区，预计将在未来十年推动日本进一步普及数位病理学。

对基因组检测和个人化医疗的需求日益增长

基因组检测和个人化医疗需求的快速成长显着推动了日本病理检测服务市场的发展。面对人口老化和慢性病的盛行率上升，基于基因谱分析的个人化治疗策略变得日益重要。预计到2032年，日本发炎性肠道疾病（IBD）的发生率将从2022年的每10万人368.3例增加至645.8例，年均成长率达5.78%，其中18岁以下患者的成长率最高。溃疡性大肠炎预计仍将是日本最常见的IBD亚型，预计到2032年，其盛行率将达到每10万人545.9例，超过克隆氏症的101.9例。慢性病盛行率的上升趋势凸显了日本IBD医疗体系亟需扩大病理检测设施并提升儿童诊断能力。病理检查室正在拓展其在次世代定序(NGS) 和生物标记分析方面的能力，以支持精准癌症治疗和罕见疾病诊断。诸如「全民医疗」等政府政策正在推动基因组医学的发展，进一步加速市场成长。私人实验室也正与製药公司合作，开发标靶治疗的伴随诊断。儘管高成本且监管复杂，但向个人化医疗的转变预计将持续推动日本病理学领域的长期成长，而实验室将在推进精准医疗方面发挥关键作用。

本报告解答的关键问题

  • 日本病理检测服务市场目前表现如何？未来几年又将如何发展？
  • 日本病理检测服务市场如何依检测类型细分？
  • 日本病理检测服务市场依检测服务类型分類的组成是怎样的？
  • 日本病理检测服务市场以最终用途分類的组成是怎样的？
  • 日本病理检测服务市场按地区分類的市场组成是怎样的？
  • 日本病理检测服务市场的价值链包含哪些阶段？
  • 日本病理检测服务市场的主要驱动因素和挑战是什么？
  • 日本病理检测服务市场的结构是怎么样的？主要参与者有哪些？
  • 日本病理检测服务市场的竞争程度如何？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本病理实验室服务市场概况

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章：日本病理检测服务市场：现状

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本病理检测服务市场（按类型划分）

  • 医院检查室
  • 独立检验机构
  • 诊断链

第七章：日本病理检测服务市场－依检测服务类型细分

  • 一般生理和临床检查
  • 影像与放射学
  • 特别检查
  • 新冠病毒检测

第八章：日本病理检测服务市场（以最终用途划分）

  • 医师转诊
  • 直接访问
  • 对于企业

第九章：日本病理检测服务市场（按地区划分）

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十章：日本病理检测服务市场的竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十一章主要企业概况

第十二章：日本病理检测服务市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十三章附录

简介目录
Product Code: SR112026A37101

The Japan pathology lab services market size reached USD 34,925.5 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 77,393.3 Million by 2034 , exhibiting a growth rate (CAGR) of 9.24 % during 2026-2034 . The market is driven by the rapid adoption of digital pathology and AI, supported by government initiatives promoting digital healthcare transformation and precision medicine. The increasing number of elderly individuals and the prevalence of chronic illnesses are driving the need for genomic testing and personalized diagnostics, prompting laboratories to enhance their capabilities in next-generation sequencing (NGS) and biomarker analysis. Strategic collaborations between pathology providers, AI startups, and pharmaceutical firms are accelerating innovations, further augmenting the Japan pathology lab services market share.

JAPAN PATHOLOGY LAB SERVICES MARKET TRENDS:

Increasing Adoption of Digital Pathology and AI Integration

The market is witnessing a significant shift toward digital pathology and artificial intelligence (AI) integration. With advancements in whole-slide imaging (WSI) and cloud-based data storage, labs are transitioning from traditional microscopy to digital platforms for faster and more accurate diagnostics. AI-powered tools are being increasingly adopted to assist pathologists in detecting anomalies, reducing human error, and improving workflow efficiency. The Japanese government's push for digital healthcare transformation, along with rising demand for precision medicine, is accelerating this trend. Japan's fiscal year 2024 budget for digital health has risen substantially to JPY 61.7 billion (approximately USD 400 Million), with an emphasis on AI diagnostics and the inclusion of electronic medical records (EMRs) to meet the increased need for pathology services resulting from an aging population. Government estimates predict a shortage of 960,000 healthcare professionals by 2040, which underscores the need for swift implementation of digital technologies in the laboratory and diagnostic sectors. United States-Japan collaborations are now focused on EMR standardization, AI development in pathology, and cross-border data exchange to digitally revamp laboratory infrastructure. Additionally, collaborations between pathology labs and AI startups are fostering innovation in automated diagnosis, particularly in cancer detection. However, challenges such as high implementation costs and data security concerns remain. Despite these barriers, the growing need for scalable and remote diagnostic solutions, especially in rural areas, is expected to drive further adoption of digital pathology in Japan over the next decade.

Rising Demand for Genomic Testing and Personalized Medicine

The accelerating demand for genomic testing and personalized medicine is significantly supporting the Japan pathology lab services market growth. As the nation confronts an increasing elderly population and a higher incidence of chronic illnesses, there is an intensifying emphasis on customized treatment strategies informed by genetic profiling. The incidences of inflammatory bowel disease (IBD) in Japan are projected to be 645.8 per 100,000 by 2032, up from 368.3 in 2022. It will increase at an annual rate of 5.78%, with the highest rise reported in patients under 18 years of age. Ulcerative colitis is also projected to continue being the major subtype in Japan with an estimated prevalence of 545.9 per 100,000 in 2032, higher than Crohn's disease at 101.9. The rising epidemic of chronic illness shows the pressing necessity of upgrading pathology laboratory facilities and upgrading pediatric diagnostic capacity in Japan's IBD care system. Pathology labs are expanding their capabilities to include next-generation sequencing (NGS) and biomarker analysis to support precision oncology and rare disease diagnosis. Government initiatives, such as the "Healthcare Policy for All Citizens," are promoting genomic medicine, further propelling market growth. Private labs are also partnering with pharmaceutical companies to develop companion diagnostics for targeted therapies. Despite the high costs and regulatory complexities, the shift toward personalized healthcare is expected to sustain long-term growth in Japan's pathology sector, with labs playing a crucial role in advancing precision medicine.

JAPAN PATHOLOGY LAB SERVICES MARKET SEGMENTATION:

Type Insights:

  • Hospital-based
  • Standalone Labs
  • Diagnostic Chains

Testing Service Insights:

  • General Physiological and Clinical Tests
  • Imaging and Radiology Tests
  • Esoteric Tests
  • COVID-19 Tests

End Use Insights:

  • Physician Referral
  • Walk-in
  • Corporate

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the Japan pathology lab services market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan pathology lab services market on the basis of type?
  • What is the breakup of the Japan pathology lab services market on the basis of testing service?
  • What is the breakup of the Japan pathology lab services market on the basis of end use?
  • What is the breakup of the Japan pathology lab services market on the basis of region?
  • What are the various stages in the value chain of the Japan pathology lab services market?
  • What are the key driving factors and challenges in the Japan pathology lab services market?
  • What is the structure of the Japan pathology lab services market and who are the key players?
  • What is the degree of competition in the Japan pathology lab services market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pathology Lab Services Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Pathology Lab Services Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Pathology Lab Services Market - Breakup by Type

  • 6.1 Hospital-based
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Standalone Labs
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Diagnostic Chains
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)

7 Japan Pathology Lab Services Market - Breakup by Testing Service

  • 7.1 General Physiological and Clinical Tests
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Imaging and Radiology Tests
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Esoteric Tests
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 COVID-19 Tests
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)

8 Japan Pathology Lab Services Market - Breakup by End Use

  • 8.1 Physician Referral
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Walk-in
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Corporate
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)

9 Japan Pathology Lab Services Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Type
    • 9.1.4 Market Breakup by Testing Service
    • 9.1.5 Market Breakup by End Use
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Type
    • 9.2.4 Market Breakup by Testing Service
    • 9.2.5 Market Breakup by End Use
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Type
    • 9.3.4 Market Breakup by Testing Service
    • 9.3.5 Market Breakup by End Use
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Type
    • 9.4.4 Market Breakup by Testing Service
    • 9.4.5 Market Breakup by End Use
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Type
    • 9.5.4 Market Breakup by Testing Service
    • 9.5.5 Market Breakup by End Use
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Type
    • 9.6.4 Market Breakup by Testing Service
    • 9.6.5 Market Breakup by End Use
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Type
    • 9.7.4 Market Breakup by Testing Service
    • 9.7.5 Market Breakup by End Use
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Type
    • 9.8.4 Market Breakup by Testing Service
    • 9.8.5 Market Breakup by End Use
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Pathology Lab Services Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Services Offered
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Services Offered
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Services Offered
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Services Offered
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Services Offered
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Pathology Lab Services Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix